Shopping Cart
- Remove All
![TargetMol](https://newstatic.targetmol.com/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,120 | Inquiry | |
50 mg | $2,780 | Inquiry | |
100 mg | $3,700 | Inquiry |
Description | Macropa-NCS is conjugated to trastuzumab as well as to the prostate-specific membrane antigen-targeting compound RPS-070.This compound is unstable in powder form and other related salt forms are recommended. |
In vitro | A stock solution of macropa-NCS at 4.4 mg/mL was prepared in a 0.1 M NaHCO3 buffer (pH 9.1) with 0.154 M NaCl and stored at -80 °C. To a saline solution of Tmab (74 μL), macropa-NCS (52 μL) and NaHCO3 buffer (266 μL) were added, resulting in final concentrations of 5.1 mg/mL for Tmab and 0.59 mg/mL for macropa-NCS. It was estimated that macropa-NCS was present at a 16-fold molar excess relative to Tmab, taking into account the molecular weight of macropa-NCS (tetra-TFA salt) as 1045.76 g/mol[1]. |
Molecular Weight | 589.66 |
Formula | C27H35N5O8S |
Cas No. | 2146095-31-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.